Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Champions Oncology (CSBR) over the last 15 years, with Q4 2025 value amounting to $2.2 million.

  • Champions Oncology's Accumulated Expenses fell 210.29% to $2.2 million in Q4 2025 from the same period last year, while for Oct 2025 it was $2.2 million, marking a year-over-year decrease of 210.29%. This contributed to the annual value of $2.6 million for FY2025, which is 1833.33% up from last year.
  • Champions Oncology's Accumulated Expenses amounted to $2.2 million in Q4 2025, which was down 210.29% from $1.8 million recorded in Q3 2025.
  • In the past 5 years, Champions Oncology's Accumulated Expenses registered a high of $2.6 million during Q2 2025, and its lowest value of $1.7 million during Q4 2022.
  • For the 5-year period, Champions Oncology's Accumulated Expenses averaged around $2.1 million, with its median value being $2.1 million (2024).
  • Examining YoY changes over the last 5 years, Champions Oncology's Accumulated Expenses showed a top increase of 12566.46% in 2021 and a maximum decrease of 1800.81% in 2021.
  • Over the past 5 years, Champions Oncology's Accumulated Expenses (Quarter) stood at $1.9 million in 2021, then decreased by 12.61% to $1.7 million in 2022, then grew by 21.14% to $2.0 million in 2023, then increased by 10.48% to $2.2 million in 2024, then decreased by 2.1% to $2.2 million in 2025.
  • Its last three reported values are $2.2 million in Q4 2025, $1.8 million for Q3 2025, and $2.6 million during Q2 2025.